Advertisement
Research Article| Volume 58, ISSUE 3, P211-215, November 20, 2007

Circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in women suffering from chronic idiopathic urticaria in relation to their pre- or post-menopausal status

  • Alicja Kasperska-Zajac
    Correspondence
    Corresponding author at: Chair and Clinical Department of Internal Diseases, Allergology and Clinical Immunology, ul. 3-go Maja 13-15, 41-800 Zabrze, Poland. Tel.: +48 322718101; fax: +48 322718110.
    Affiliations
    Chair and Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland
    Search for articles by this author
  • Zenon Brzoza
    Affiliations
    Chair and Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland
    Search for articles by this author
  • Barbara Rogala
    Affiliations
    Chair and Clinical Department of Internal Diseases, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland
    Search for articles by this author

      Abstract

      Objective

      As chronic urticaria in pre-menopausal women was accompanied by lower serum concentration of DHEA-S and because it had been known that endocrine profiles changed along with ageing, in the present study we investigated DHEA-S behaviour in post-menopausal women suffering from chronic idiopathic urticaria (CIU).

      Methods

      Serum concentration of DHEA-S was measured in 32 post-menopausal women, aged between 49 and 66, suffering from CIU, as well as in 30 healthy subjects matched for age, body mass index, and years since menopause.

      Results

      No statistical difference in DHEA-S serum concentration was found between the CIU patients and the controls (median 99.63 ug/dl versus 108.25 ug/dl, respectively).

      Conclusions

      The observations made recently and those of our previous results may point to the existence of two different hormonal patterns of DHEA-S circulating concentration in female patients suffering from CIU, depending on age of the disease onset. The scope of the study has been limited however, due to the small number of subjects.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Maturitas
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Greaves M.W.
        Chronic urticaria.
        N Engl J Med. 1995; 332: 1767-1772
        • Angioni S.
        • Petraglia F.
        • Genezzani A.R.
        Immune-endocrine correlations: a new aspect in human physiology.
        Acta Eur Fertil. 1991; 22: 167-170
        • Lucas J.A.
        • Ahmed S.A.
        • Casey M.L.
        • MacDonald P.C.
        Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice fed dehydroisoandrosterone.
        J Clin Invest. 1985; 75: 2091-2093
        • Daynes R.A.
        • Dudley D.J.
        • Araneo B.A.
        Regulation of murine lymphokine production in vivo II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells.
        Eur J Immunol. 1990; 20: 793-802
        • Dillon J.S.
        Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders.
        Curr Drug Targets Inflamm Allergy. 2005; 4: 377-385
        • Sulcova J.
        • Hill M.
        • Hampl R.
        • Starka L.
        Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects.
        J Endocrinol. 1997; 154: 57-62
        • Burger H.G.
        • Dudley E.C.
        • Cui J.
        • Dennerstein L.
        • Hopper J.L.
        A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.
        J Clin Endocrinol Metab. 2000; 85: 2832-2838
        • Cumming D.C.
        • Rebar R.W.
        • Hopper B.R.
        • Yen S.S.
        Evidence for an influence of the ovary on circulating dehydroepiandrosterone sulfate levels.
        J Clin Endocrinol Metab. 1982; 54: 1069-1071
        • Cutolo M.
        • Seriolo B.
        • Villaggio B.
        • Pizzorni C.
        • Craviotto C.
        • Sulli A.
        Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis.
        Ann N Y Acad Sci. 2002; 966: 131-142
        • Tagawa N.
        • Tamanaka J.
        • Fujinami A.
        • et al.
        Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pergnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism.
        Clin Chem. 2000; 46: 523-528
        • Barry N.N.
        • McGuire J.L.
        • van Vollenhoven R.F.
        Dehydroepiandrosterone in systemic lupus erythematosus: relationship between dosage, serum levels, and clinical response.
        J Rheumatol. 1998; 25: 2352-2356
        • Kasperska-Zajac A.
        • Brzoza Z.
        • Rogala B.
        Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria.
        J Dermatol Sci. 2006; 41: 80-81
        • Kasperska-Zajac A.
        • Brzoza Z.
        • Rogala B.
        Lower serum concentration of dehydyroepiandrone sulphate in patients with chronic idiopathic urticaria.
        Allergy. 2006; 61: 1489-1490
        • La Montagna G.
        • Baruffo A.
        • Buono G.
        • Valentini G.
        Dehydroepiandrosterone sulphate serum levels in systemic sclerosis.
        Clin Exp Rheumatol. 2001; 19: 21-26
        • Kaufert P.A.
        • Gilbert P.
        • Tate R.
        Defining menopausal status: the impact of longitudinal data.
        Maturitas. 1987; 9: 217-226
        • Schwartz K.E.
        Autoimmunity, dehydroepiandrosterone (DHEA), and stress.
        J Adoles Health. 2002; 30S: 37-43
        • Humphreys F.
        • Hunter J.A.A.
        The characteristics of urticaria in 390 patients.
        Br J Dermatol. 1998; 138: 635-638
        • Piconi S.
        • Trabattoni D.
        • Iemoli E.
        • et al.
        Immune profiles of patients with chronic idiopathic urticaria.
        Int Arch Allergy Immunol. 2002; 128: 59-66
        • Verthelyi D.
        • Klinman D.M.
        Sex hormone levels correlate with the activity of cytokine-secreting cells in vivo.
        Immunology. 2000; 100: 384-390
        • Brzoza Z.
        • Kasperska-Zajac A.
        • Rogala B.
        Serum prolactin concentration and its relationship with dehydroepiandrosterone sulfate concentration in chronic urticaria patients with positive and negative response to autologous serum skin test.
        Allergy. 2007; 62: 566-567
      1. Kasperska-Zajac A, Brzoza Z, Rogala B. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine 2007, (in press).